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Background/Aims: Capsule endoscopy (CE) is widely used for the diagnosis of 
small bowel diseases. The clinical performance and complications of small bowel 
CE, including completion rate, capsule retention rate, and indications, have been 
previously described in Korea. This study aimed at estimating the recent changes 
in clinical performance and complications of small bowel CE based on 17-year 
data from a Korean Capsule Endoscopy Registry. 
Methods: CE registry data from 35 hospitals were retrospectively analyzed. Clin-
ical information, including completion rate, capsule retention rate, and indica-
tions, was collected and analyzed. In addition, the most recent 5-year data for CE 
examinations were compared with the previous 12-year data. 
Results: A total of 4,650 CE examinations were analyzed. The most common in-
dication for CE was obscure gastrointestinal bleeding (OGIB). The overall incom-
plete examination rate was 16% and the capsule retention rate was 3%. Crohn’s 
disease was a risk factor for capsule retention. Inadequate bowel preparation was 
significantly associated with capsule retention and incomplete examination. An 
indication other than OGIB was a risk factor for incomplete examination. A re-
cent increasing trend of CE diagnosis of Crohn’s disease was observed. The most 
recent 5-year incomplete examination rate for CE examinations decreased com-
pared with that of the previous 12 years. 
Conclusions: The 17-year data suggested that CE is a useful and safe tool for diag-
nosing small bowel diseases. The incomplete examination rate of CE decreased 
with time, and OGIB was consistently the main indication for CE. Inadequate 
bowel preparation was significantly associated with capsule retention and incom-
plete examination.
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INTRODUCTION
Since Capsule endoscopy (CE) was introduced in 2000, 
it has been widely used as the main tool for diagnosing 
small bowel diseases [1]. Although CE is useful for diag-
nosing small bowel diseases, it has some limitations in-
cluding incomplete examinations and capsule retention 
[2-4]. Occasionally, capsules cannot reach the cecum due 
to various causes, thus leading to incomplete examina-
tion of the small bowel. Another problem is capsule re-
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tention. Most patients in whom capsule retention oc-
curs are asymptomatic; however, some require surgical 
or enteroscopic capsule removal [4-9]. The clinical per-
formance and complications of small bowel CE include 
completion rate, capsule retention rate, and indications 
[2,3]; these have also been described in Korea [10]. This 
study aimed to investigate the clinical performance and 
complications of small bowel CE based on 17-year data 
from a Korean Capsule Endoscopy Registry. Further-
more, recent changes in the clinical performance and 
complications of small bowel CE were also evaluated.
METHODS
CE registry data from 35 hospitals, collected between Oc-
tober 2002 and April 2019, were retrospectively analyzed. 
Clinical information, including demographic data, com-
pletion rate, capsule retention rate, indications, CE diag-
nosis, and bowel preparation data, was collected and an-
alyzed. From September 2014, health insurance benefits 
were provided to patients with obscure gastrointestinal 
bleeding (OGIB) in Korea. However, for patients with 
small bowel tumor(s), Crohn’s disease, and other small 
bowel diseases, a patient burden of 80% was applied. As 
such, data from the most recent 5 years (September 2014 
to April 2019) were compared with those from the previ-
ous 12 years (October 2002 to August 2014).
Indications for CE included OGIB, abdominal pain, 
chronic diarrhea, small bowel tumor(s), Crohn’s disease, 
weight loss, protein-losing enteropathy, and screening. 
OGIB was defined as bleeding of unknown cause that 
persisted or recurred after initial upper gastrointestinal 
endoscopy and colonoscopy with negative results [11,12]. 
In addition to overt bleeding (melena or hematochezia), 
occult bleeding (persistent iron deficiency anemia or 
positive stool occult blood) was also considered OGIB 
[12,13]. 
Before CE examinations, patients were offered a bowel 
preparation regimen according to clinician preferenc-
es. Options for the bowel preparation included nil per os 
(NPO), polyethylene glycol (PEG), PEG + ascorbic acid, 
sodium phosphate (NaP), picosulfate, or others. Bowel 
preparation quality was categorized by independent ex-
aminers as follows: excellent, ≥ 75% of the mucosa visu-
alized; good, 50% to 74% of the mucosa visualized; fair, 
25% to 49% of the mucosa visualized; poor, ≤ 24% of the 
mucosa visualized [14]. For the purpose of study analy-
sis, excellent or good bowel preparation were deemed 
adequate, and fair or poor preparation were deemed in-
adequate [15]. Comparison was performed between ade-
quate and inadequate bowel preparation quality. 
CE diagnoses were based on CE structured terminolo-
gy. Complete examination was defined when the capsule 
reached the cecum during the recording time [2,3]. Cap-
sule retention was defined when the capsule remained 
in the digestive tract for > 2 weeks [2,10]. Completion and 
capsule retention rates were calculated, and risk factors 
affecting incomplete examination and capsule retention 
were also investigated. Acquisition of informed consent 
was exempted and the study design was approved by the 
Institutional Review Board of Seoul Metropolitan Gov-
ernment Seoul National University Boramae Medical 
Center (approval number: 20190802/10-2019-62/091).
Data are expressed as mean ± standard deviation (SD) 
for continuous variables and number (%) for categori-
cal variables. Risk factors for incomplete examination 
and capsule retention were analyzed using logistic re-
gression models. Statistical analysis was performed us-




A total of 4,650 CE examinations were analyzed. The 
mean ± SD age of the study population was 53.5 ± 18.8 
years, and 60.3% was male. The overall incomplete ex-
amination rate was 16.3%, and the capsule retention rate 
was 3%. The incomplete examination rate of recent CE 
examinations (from September 2014 to April 2019) de-
creased compared with that of previous examinations 
(9.4% vs. 18.9%, p < 0.001) (Table 1). The most common 
indication for CE was OGIB (64.4%). Patients in whom 
the indication for CE was OGIB accounted for 68.8% in 
recent CE examinations and 62.7% in previous CE ex-
aminations (p < 0.001) (Table 2). 
CE diagnoses
Positive CE diagnosis was obtained in 63.8% CE exam-
inations, while negative (normal) CE diagnosis was ob-
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tained in 36.2% CE examinations. Recent CE examina-
tions yielded normal results in 28.4%, which was lower 
than the normal results in previous CE examinations 
(38.5%) (p < 0.001). CE diagnoses are summarized in Table 
3. A recent increasing trend of CE diagnosis of Crohn’s 
disease was observed (6.3% vs. 8.5%, p = 0.014). Regarding 
nonsteroidal anti-inflammatory drug (NSAID) enterop-
athy, significant changes with time were not observed 
(5.7% vs. 6.5%, p = 0.305).
Factors associated with incomplete examination and 
capsule retention
Factors associated with incomplete examination includ-
ed inadequate bowel preparation and an indication oth-
er than OGIB (Table 4). Crohn’s disease was a risk factor 
for capsule retention, and inadequate bowel preparation 
was significantly associated with capsule retention (Ta-
ble 5). The capsule retention rate was the highest among 
patients with Crohn’s disease (Table 6). 
Bowel preparation
The quality of bowel preparation significantly differed 
according to bowel preparation regimen (Table 7). When 
the proportion of adequate bowel preparation after in-
gesting the bowel preparation regimen was compared 
pairwise with that after NPO, significant differences 
Table 2. Indications for capsule endoscopy
Variable Total ~Aug. 31, 2014 Sep. 1, 2014~
Obscure GI bleeding 2,965 (64.4) 2,110 (62.7) 790 (68.8)a
Overt 2,445 (53.1) 1,755 (52.2) 638 (55.6)
Occult 520 (11.3) 355 (10.5) 152 (13.2)
Abdominal pain 724 (15.7) 594 (17.7) 117 (10.2)
Crohn’s disease 212 (4.6) 119 (3.5) 86 (7.5)a
Small bowel tumor 166 (3.6) 122 (3.6) 42 (3.7)
Chronic diarrhea 171 (3.7) 118 (3.5) 51 (4.4)
Weight loss 19 (0.4) 18 (0.5) 1 (0.1)
Cancer of unknown primary site 4 (0.1) 3 (0.1) 0
Protein-losing enteropathy 15 (0.3) 6 (0.2) 7 (0.6)
Behcet’s disease, TB enteritis 44 (1.0) 21 (0.6) 23 (2.0) 
Ileus 13 (0.3) 5 (0.1) 8 (0.7)
Screening 214 (4.6) 209 (6.2) 2 (0.2)
Values are presented as number (%).
GI, gastrointestinal; TB, tuberculous.
aIncreased trend.
Table 1. Demographic information and incomplete examination and retention rates
Variable Total ~Aug. 31, 2014 Sep. 1, 2014~
Age 53.5 ± 18.8 53.1 ± 18.1 55.0 ± 20.5
Male sex 2,804 (60.3) 2,067 (61.1) 681 (58.2)
Incompletion 678 (16.3) 570 (18.9) 108 (9.4)a
Retention 125 (3.0) 105 (3.2) 20 (2.6)
Values are presented as mean ± SD or number (%).
aDecreased trend.
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were identified for PEG 4 L, PEG + ascorbic acid 2 L, and 
NaP (p = 0.017, p < 0.001, p = 0.028, respectively). When 
Bonferroni correction was applied for multiple com-
parisons (p < 0.0125), the proportion of adequate bowel 
Table 3. Capsule endoscopic diagnosis
Variable Total ~Aug. 31, 2014 Sep. 1, 2014~
Normal 1,647 (36.2) 1,285 (38.5) 322 (28.4)a
Vascular lesions
Angiodysplasia, telangiectasia, Dieulafoy’s lesion 442 (9.7) 349 (10.4) 87 (7.7)
Bleeding of unidentified origin 234 (5.1) 122 (3.7) 109 (9.6)
Varices 12 (0.3) 10 (0.3) 2 (0.2)
Inflammatory lesions
 Erosion, not signified 365 (8.0) 233 (7) 130 (11.5)
Ulcer, not signified 469 (10.3) 352 (10.5) 112 (9.9)
Hemorrhagic enteropathy 31 (0.7) 28 (0.8) 3 (0.3)
Congestive enteropathy 13 (0.3) 13 (0.4) 6 (0.5)
H-S purpura, vasculitis 11 (0.2) 10 (0.3) 1 (0.1)
Ischemic enteritis 9 (0.2) 6 (0.2) 3 (0.3)
NSAID enteropathy 267 (5.9) 190 (5.7) 74 (6.5)
TB enteritis 30 (0.7) 16 (0.5) 12 (1.1)
Behcet’s enteritis 33 (0.7) 22 (0.7) 11 (1.0) 
Radiation enteritis 9 (0.2) 8 (0.2) 0
Eosinophilic enteritis 18 (0.4) 10 (0.3) 6 (0.5)
Crohn’s disease 316 (6.9) 211 (6.3) 96 (8.5)b
CMUSE 3 (0.1) 1 (0) 2 (0.2)
Tumor lesions
Lymphoid hyperplasia 25 (0.5) 22 (0.7) 3 (0.3)
Lymphangiectasia 30 (0.7) 17 (0.5) 12 (1.1)
Malignant tumor 50 (1.1) 40 (1.2) 9 (0.8)
Submucosal tumor 146 (3.2) 120 (3.6) 24 (2.1)
Polyp, adenomatous 25 (0.5) 21 (0.6) 4 (0.4)
Polyp, non-neoplastic 134 (2.9) 105 (3.1) 25 (2.2)
Peutz-Jeghers syndrome 10 (0.2) 7 (0.2) 3 (0.3)
Hemangioma 4 (0.1) 2 (0.1) 2 (0.2)
Lymphangioma 3 (0.1) 2 (0.1) 1 (0.1)
Others 220 (4.8) 138 (4.1) 82 (7.2)
Values are presented as number (%). 
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preparation was different only between PEG + ascorbic 
acid 2 L and NPO. PEG 2 L was previously the most com-
monly used regimen (47.9%); however, recently, the PEG 
+ ascorbic acid regimen has become the most popular 
(58.1%) (Table 8). 
DISCUSSION
In this registry-based study including 4,650 CE exam-
inations, the incomplete examination and capsule re-
tention rates were determined. This study revealed an 
incomplete examination rate of 16%, which is similar to 
that reported in previous studies [2,3]. The capsule re-
tention rate was 3%, which is slightly higher than that 
reported in previous studies [2,3]. The incomplete exam-
ination rate of recent CE (September 2014 to April 2019) 
decreased compared with that of previous CE (October 
2002 to August 2014). With the extended battery life of 
newer CE technologies, more capsules have reached 
the ileocecal valve and cecum, leading to a decrease in 
the number of incomplete examinations [16,17]. With 
technical advances in radiological examinations, such 
as computed tomography enterography and magnet-
Table 6. Capsule retention rates according to indications for 
capsule endoscopy 
Indications of capsule endoscopy No. (%)
Obscure GI bleeding 82 (3.1)
Abdominal pain 20 (3.0) 
Crohn’s disease 12 (6.3)
Small bowel tumor 1 (0.7)
Screening 0
Chronic diarrhea 2 (1.3)
GI, gastrointestinal.
Table 4. Factors associated with incomplete examination
Variable
Crude Age and sex adjusted
OR 95% CI p value OR 95% CI p value
Age 1.005 1.001–1.009 0.026
Male sex 0.911 0.771–1.076 0.274
Indication for capsule endoscopy
OGIB vs. others 0.761 0.642–0.902 0.002 0.712 0.597–0.850 < 0.001
 Crohn’s disease vs. others 0.864 0.574–1.301 0.484 0.966 0.636–1.467 0.871
Small bowel tumor vs. others 0.827 0.523–1.308 0.418 0.868 0.548–1.375 0.548
Bowel preparation
Inadequate vs. adequate 1.757 1.479–2.086 < 0.001 1.750 1.472–2.080 < 0.001
OR, odds ratio; CI, confidence interval; OGIB, obscure gastrointestinal bleeding.
Table 5. Factors associated with capsule retention
Variable
Crude Age and sex adjusted
OR 95% CI p value OR 95% CI p value
Age 0.999 0.989–1.008 0.814
Male sex 0.83 0.580–1.188 0.309
Indication for capsule endoscopy
OGIB vs. others 1.083 0.745–1.575 0.677 1.092 0.743–1.604 0.654
 Crohn’s disease vs. others 2.264 1.226–4.182 0.009 2.380 1.258–4.505 0.008
Small bowel tumor vs. others 0.213 0.030–1.533 0.124 0.209 0.029–1.506 0.120 
Bowel preparation
Inadequate vs. adequate 2.434 1.677–3.533 < 0.001 2.412 1.657–3.510 < 0.001
OR, odds ratio; CI, confidence interval; OGIB, obscure gastrointestinal bleeding.
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ic resonance enterography, more patients with small 
bowel stricture(s) can be diagnosed before undergoing 
CE. However, the decrease in capsule retention rate 
over time was not statistically significant in our study. 
Moreover, our data lacked radiological examination re-
sults and, thus, analysis in this regard was not possible. 
The most common indication for CE was OGIB (64.4%), 
which is consistent with results reported in previous 
studies [2,3,10]. In our study, recent CE examinations 
had more OGIB indications than previous CE examina-
tions (p < 0.001), which can be explained by the inception 
of health insurance coverage for patients with OGIB in 
September 2014.
Recently, the incidence of Crohn’s disease has been 
found to be increasing in Korea [18]. Our study revealed 
a recent increasing tendency of indications and CE di-
agnosis of Crohn’s disease. CE diagnosis of NSAID en-
teropathy demonstrated an increasing tendency without 
statistical significance. The increase in NSAID enterop-
athy can be attributed to the aging population. In our 
study, the proportion of normal results was smaller in 
recent CE examinations than in previous examinations. 
Recent advances in CE technology with improved reso-
lution may have led to more lesion detection and fewer 
patients diagnosed with normal findings. 
Our study revealed that factors associated with incom-
plete examination were inadequate bowel preparation 
and indications other than OGIB, which is consistent 
Table 7. Bowel preparation quality according to bowel preparation method
Variable NPO PEG 4 L PEG 2 L PEG + Asc 2 L NaP p value
Quality < 0.001
Excellent 149 (21.4) 104 (16.1) 165 (10.8) 92 (13.5) 89 (30.3)
Good 340 (48.9) 388 (60.1) 874 (57.5) 289 (42.6) 138 (46.9)
Fair 161 (23.2) 119 (18.4) 368 (24.2) 215 (31.7) 53 (18.0) 
Poor 45 (6.5) 35 (5.4) 114 (7.5) 83 (12.2) 14 (4.8)
Acceptability < 0.001
Adequate 489 (70.4) 492a (76.2) 1,039 (68.3) 381a (56.1) 227a (77.2)
Inadequate 206 (29.6) 154 (23.8) 482 (31.7) 298 (43.9) 67 (22.8)
p value vs. NPO Reference 0.017 0.333 < 0.001 0.028
Values are presented as number (%). 
NPO, nil per os; PEG, polyethylene glycol; Asc, ascorbic acid; NaP, sodium phosphate.
aStatistically significant in comparison with NPO (p < 0.05).
Table 8. Trends in bowel preparation methods 
Variable Total ~Aug. 31, 2014 Sep. 1, 2014~
NPO 704 (17.5) 560 (19.2) 144 (12.9)
PEG 4 L 658 (16.3) 546 (18.7) 111 (10.0) 
PEG 2 L 1,553 (38.5) 1,398 (47.9) 155 (13.9)
PEG + Asc 2 L 681 (16.9) 34 (1.2) 646 (58.1)
NaP 297 (7.4) 297 (10.2) 0
Picosulfate 64 (1.6) 8 (0.3) 56 (4.8)
Others 77 (1.9) 77 (2.7) 0
Values are presented as number (%). 
NPO, nil per os; PEG, polyethylene glycol; Asc, ascorbic acid; NaP, sodium phosphate.
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with the results of a previous study [10]. With adequate 
bowel preparation, CE is more likely to be completed. 
Blood materials in patients with gastrointestinal bleed-
ing appear to act as laxatives, thus helping the capsule 
proceed through the ileocecal valve. In our study, inad-
equate bowel preparation was significantly associated 
with capsule retention, which is also consistent with 
the results of previous studies [2,10]. The presence of 
stenotic portions in the small bowel may lead to both 
inadequate bowel preparation and capsule retention. 
Additionally, fecal materials stuck in the stenotic por-
tion may result in capsule retention. Although causality 
was difficult to determine, our study revealed that in-
adequate bowel preparation was significantly associated 
with capsule retention. Crohn’s disease was a risk fac-
tor for capsule retention and the capsule retention rate 
was the highest among patients with the indication of 
Crohn’s disease. Special caution or using a patency cap-
sule will be needed in patients with Crohn’s disease. 
In this study, bowel preparation quality was affected 
by the bowel preparation regimen. PEG 4 L or NaP more 
favorably affected bowel preparation than NPO; howev-
er, PEG + ascorbic acid resulted in worse bowel prepa-
ration than NPO. In our study, the recent data revealed 
that PEG + ascorbic acid regimen was the most widely 
used. This can be explained by the fact that recent guide-
lines recommend that CE should be performed as soon 
as possible (generally after colonoscopy) in patients with 
overt, obscure bleeding [11], and PEG + ascorbic acid has 
recently become the most popular regimen for colonos-
copy in Korea [19]. The time interval from the ingestion 
of the bowel preparation regimen to performing CE can 
be delayed because performing colonoscopy and clini-
cian’s decision-making to perform CE after colonoscopy 
can take time. This time delay may adversely affect bowel 
preparation quality [20,21], because debris and intestinal 
fluid can affect preparation of the distal small bowel [22]. 
Our study had some limitations, the first of which 
was its retrospective design and, as such, may have been 
susceptible to selection bias. Moreover, our data may 
have been susceptible to the under-reporting of com-
plications. Second, our investigation was a multi-center, 
registry-based study, and the data collection methods 
used at each institution were not monitored. There was 
no auditing system to control data collection. Howev-
er, this was a large study based on 17-year registry data. 
Time trends were also investigated between recent and 
previous data. 
In conclusion, our 17-year data suggest that CE is a 
useful and safe tool for diagnosing small bowel diseases. 
The incomplete examination rate of CE decreased with 
time and OGIB was consistently the primary indication 
for CE. Inadequate bowel preparation was significantly 
associated with capsule retention and incomplete exam-
ination.
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